Immutep shares update on Phase I study of LAG-3 agonist antibody for autoimmune diseases, showing positive safety & efficacy ...
There are growing concerns among several nations regarding the genuineness of anti-rabies vaccines administered to victims - ...
For decades, the FDA made it nearly impossible to know which factories were manufacturing your generic medications. ProPublica built a tool to show you. Here’s how we did it.
Immutep has announced positive phase one trial results for a compound that could help treat autoimmune diseases.
Immutep ( ($IMMP) ) has issued an announcement. On 22 December 2025, Immutep reported positive initial results from a placebo-controlled, ...
Malaria vaccine shows over 50% efficacy in adults following controlled human malaria infection, supporting further trials in children.
Single-ascending dose portion of study has successfully completed 2.5 and 7 mg / kg levelsDose dependent immunosuppressive effect against a strong foreign antigen observed with continued favourable ...
Public-private partnership aims to improve osteoarthritis research, diagnosis and treatment----PROBE will leverage data from over 70 million ...
The Print on MSN
The curious case of the fake Abhayrab rabies vaccine
Fears mount as authorities worldwide warn travellers who received the Abhayrab rabies vaccine in India to get replacement ...
Mali: A phase 2 randomized controlled trial published in The Lancet Infectious Diseases has revealed that a multistage malaria vaccine provided encouraging protection against controlled human malaria ...
Indivior PLC today announced results from a randomized, double-blind clinical trial published in JAMA Network Open. The study found that both the 100-mg and 300-mg monthly maintenance doses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback